Bakkt Holdings
BKKT
Bit Origin
BTOG
Intchains Group
ICG
4
Mawson Infrastructure
MIGI
5
FRMO CORP
FRMO
Outlook Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of ONS-5010/LYTENAVA. Its pipeline includes unmet patient needs, repackaged IV bevacizumab, and anti-VEGF. The company was founded by Pankaj Mohan on January 5, 2010 and is headquartered in Iselin, NJ.